4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001415889-24-012238
CEO sold 11,427 shares at $16.94 ($193,573)
- CEO acquired 22,391 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DAVIS STEPHEN CEO | 2024-05-01 | Option exercise | +22,391 | 166,658 | D | ||
| DAVIS STEPHEN CEO | 2024-05-02 | Sale | −11,427 | $16.94 | $193,573 | 155,231 | D |
| Derivatives | |||||||
| DAVIS STEPHEN CEO | 2024-05-01 | Option exercise · Restricted Stock Units | −22,391 | 67,173 | D | ||
| Open-market sales · 11,427 sh · avg $16.94 · $193,573 | |||||||
Loading xslF345X05/form4-05032024_060513.xml…